Comparison of Cervical Cerclage by Vaginal and by Laparoscopic Transabdominal Routes in the Periconceptional Period
NCT ID: NCT06788873
Last Updated: 2025-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
60 participants
OBSERVATIONAL
2022-05-15
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-Term Patient-Reported Maternal Outcomes Following Abdominal Cerclage for the Prevention of Preterm Birth
NCT06875401
Cerclage for Singletons With Short Cervix Without Prior Preterm Birth
NCT02716922
Obstetric Outcome in Pregnancies Treated With Laparoscopic Cerclage
NCT05863481
Cerclage After Full Dilatation Caesarean Section
NCT04110704
Cervical Cerclage for Preventing Spontaneous Preterm Birth in Singleton Pregnancies Without Prior Spontaneous Preterm Birth and With Short Transvaginal Ultrasound Cervical Length
NCT02746900
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For patients who undergo elective vaginal cervical cerclage at the division of Obstetrics and Prenatal Age Medicine or laparoscopic cerclage at the division of Gynecology and Human Reproductive Pathophysiology, the normal care pathway does not include additional follow-up visits for outpatient follow-up visits.
Regarding data collected in the past as part of the normal care pathway, patients will be asked to give informed consent in the context of a follow-up visit at which a practice staff member will be present.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single pregnancy and vaginal cerclage
Participants with a single pregnancy and unfavorable obstetrical history (at least two preterm deliveries or abortions in the 2nd trimester of pregnancy) who underwent elective cervical cerclage vaginally between 01/01/2002 and 31/12/2020
Data comparison
For each participant, information will be collected on:
* Gestational age at the time the cerclage was performed
* Parity
* Age
* BMI
* Ethnicity
* Number of preterm deliveries
* Gestational age of previous preterm deliveries
* Previous uterine and/or cervix surgery (previous cerclage, conization, metroplasty, or other)
* Type of cerclage performed
* Operative times
* Days of hospitalization
* Surgical complications
* Gestational age at the time of delivery
* Mode of delivery (spontaneous, operative or cesarean)
* Infant's weight at birth
* Apgar at 1' and 5' minute
* Ph newborn
* Possible admission to neonatal intensive care unit.
No pregnancy and laparoscopic transabdominal cervical cerclage
Non-pregnant participants (with the same anamnestic characteristics as the first group) who underwent elective transabdominal laparoscopic cervical cerclage in the periconceptional period.
Data comparison
For each participant, information will be collected on:
* Gestational age at the time the cerclage was performed
* Parity
* Age
* BMI
* Ethnicity
* Number of preterm deliveries
* Gestational age of previous preterm deliveries
* Previous uterine and/or cervix surgery (previous cerclage, conization, metroplasty, or other)
* Type of cerclage performed
* Operative times
* Days of hospitalization
* Surgical complications
* Gestational age at the time of delivery
* Mode of delivery (spontaneous, operative or cesarean)
* Infant's weight at birth
* Apgar at 1' and 5' minute
* Ph newborn
* Possible admission to neonatal intensive care unit.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data comparison
For each participant, information will be collected on:
* Gestational age at the time the cerclage was performed
* Parity
* Age
* BMI
* Ethnicity
* Number of preterm deliveries
* Gestational age of previous preterm deliveries
* Previous uterine and/or cervix surgery (previous cerclage, conization, metroplasty, or other)
* Type of cerclage performed
* Operative times
* Days of hospitalization
* Surgical complications
* Gestational age at the time of delivery
* Mode of delivery (spontaneous, operative or cesarean)
* Infant's weight at birth
* Apgar at 1' and 5' minute
* Ph newborn
* Possible admission to neonatal intensive care unit.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥18 years
* Obtaining informed consent form
* Availability of clinical-demographic data
Exclusion Criteria
18 Years
44 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elisa Montaguti, MD
Role: PRINCIPAL_INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ROUND-21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.